Scholars Central

CommentaryPublished 2014

Antihypertensive Drugs in the Elderly: Risks and Benefits as Evaluated by the FORTA Method

Authors: Kuhn-Thiel AM, Wehling M

Gerontology & Geriatric Research

Volume 3 · Issue 4 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The management of polypharmacy in the elderly is a growing concern worldwide. Taking multiple medications can cause more harm than good, given that an estimated 100,000 medication-related deaths occur in the U.S. annually. Specific criteria were established by Beers (1997) for drugs to avoid in elderly patients. Although widely used, no clinical endpoints were improved, thus stressing the need for additional positive labeling of drugs as data on morbidity, mortality and safety become available for this patient collective. The FORTA (Fit fOR The Aged) method is the first approach combining positive and negative labeling of drugs. Class A drug is indispensable, B drugs have some restrictions, and C drugs are critical and need careful balancing of desired/undesired effects. D drugs should generally be avoided. Commonly-used medications for major diseases, among them hypertension, were assigned these labels in the FORTA list according to evidence as to age-appropriateness by an expert panel in a Delphi Consensus Procedure. In hypertension, RAS-inhibitors and long-acting dihydropyridine calcium blockers are A drugs, diuretics and beta blockers B drugs. This means that uncomplicated hypertension is preferentially treated by A drugs, B drugs are only given if A drugs are exhausted. C drugs represent second line compounds such as moxonidine or spironolactone which are difficult to use. The D drugs clonidine or verapamil should be avoided in the elderly. Use of the FORTA list will support general practitioners struggling with polypharmacy with multiple diagnoses, as prioritization is possible not only for one disease, but also across therapeutic areas.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Gerontology & Geriatric Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalGerontology & Geriatric Research
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Kuhn-Thiel AM”
  • BylineArticles whose byline prints “Wehling M”